The assignment provides a thorough analysis of GlaxoSmithKline's financial ratios, using data from the past four years. The report covers various aspects such as profitability, liquidity, and gearing ratios. It highlights strengths and weaknesses in these areas and offers suggestions for improvement. The document is well-structured and provides valuable insights into GSK's financial performance.